You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 May 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) on Monday reported updated positive survival observations from its ongoing Phase 1 trial of liraltagene autoleucel (lira-cel), an investigational CAR-T therapy for recurrent ova...
11 May 2026 - Biopharmaceutical company Poolbeg Pharma plc (AIM: POLB) disclosed on Monday that it has received formal notification that the Canadian patent office has granted its patent application covering POLB 001 for the prevention of cancer immu...
11 May 2026 - Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF) reported on Monday that its customer UpFront Diagnostics has commercially launched the LVOne stroke triage blood test in the UK following UKCA marking and deployment with the London Ambulan...
11 May 2026 - Cambridge-based biotechnology company 4basebio PLC (AIM: 4BB) announced on Monday that it has launched a high-capacity single-stranded DNA (ssDNA) platform designed to support the development of next-generation genetic therapies, includ...
11 May 2026 - Chinese biopharmaceutical company Harbour BioMed (HKEX:02142) announced on Friday that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for HBM7004, enabling the initiation of a first-...
11 May 2026 - Chinese biopharmaceutical company Mabwell (SH:688062) (HK:02493) announced on Friday that the Investigational New Drug (IND) application for 9MW5211, its independently developed novel antibody, has received clearance from the US Food an...
11 May 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Sunday that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted a third Breakthrough Therapy...